243 related articles for article (PubMed ID: 18328816)
1. Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid alpha-glucosidase (alglucosidase alfa): insight into the complex formation mechanism.
Yoshimizu M; Tajima Y; Matsuzawa F; Aikawa S; Iwamoto K; Kobayashi T; Edmunds T; Fujishima K; Tsuji D; Itoh K; Ikekita M; Kawashima I; Sugawara K; Ohyanagi N; Suzuki T; Togawa T; Ohno K; Sakuraba H
Clin Chim Acta; 2008 May; 391(1-2):68-73. PubMed ID: 18328816
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and structural study on a S529V mutant acid α-glucosidase responsive to pharmacological chaperones.
Tajima Y; Saito S; Ohno K; Tsukimura T; Tsujino S; Sakuraba H
J Hum Genet; 2011 Jun; 56(6):440-6. PubMed ID: 21471980
[TBL] [Abstract][Full Text] [Related]
3. Molecular interaction of imino sugars with human alpha-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease.
Sugawara K; Tajima Y; Kawashima I; Tsukimura T; Saito S; Ohno K; Iwamoto K; Kobayashi T; Itoh K; Sakuraba H
Mol Genet Metab; 2009 Apr; 96(4):233-8. PubMed ID: 19181556
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
Rawlings AJ; Lomas H; Pilling AW; Lee MJ; Alonzi DS; Rountree JS; Jenkinson SF; Fleet GW; Dwek RA; Jones JH; Butters TD
Chembiochem; 2009 Apr; 10(6):1101-5. PubMed ID: 19294724
[TBL] [Abstract][Full Text] [Related]
5. Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II.
Okumiya T; Kroos MA; Vliet LV; Takeuchi H; Van der Ploeg AT; Reuser AJ
Mol Genet Metab; 2007 Jan; 90(1):49-57. PubMed ID: 17095274
[TBL] [Abstract][Full Text] [Related]
6. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
[TBL] [Abstract][Full Text] [Related]
7. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
[TBL] [Abstract][Full Text] [Related]
8. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
Luan Z; Higaki K; Aguilar-Moncayo M; Ninomiya H; Ohno K; García-Moreno MI; Ortiz Mellet C; García Fernández JM; Suzuki Y
Chembiochem; 2009 Nov; 10(17):2780-92. PubMed ID: 19830760
[TBL] [Abstract][Full Text] [Related]
9. Structural modeling of mutant alpha-glucosidases resulting in a processing/transport defect in Pompe disease.
Sugawara K; Saito S; Sekijima M; Ohno K; Tajima Y; Kroos MA; Reuser AJ; Sakuraba H
J Hum Genet; 2009 Jun; 54(6):324-30. PubMed ID: 19343043
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease.
Parenti G; Zuppaldi A; Gabriela Pittis M; Rosaria Tuzzi M; Annunziata I; Meroni G; Porto C; Donaudy F; Rossi B; Rossi M; Filocamo M; Donati A; Bembi B; Ballabio A; Andria G
Mol Ther; 2007 Mar; 15(3):508-14. PubMed ID: 17213836
[TBL] [Abstract][Full Text] [Related]
11. Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
Butters TD; Dwek RA; Platt FM
Glycobiology; 2005 Oct; 15(10):43R-52R. PubMed ID: 15901676
[TBL] [Abstract][Full Text] [Related]
12. Stabilising normal and mis-sense variant alpha-glucosidase.
Kakavanos R; Hopwood JJ; Lang D; Meikle PJ; Brooks DA
FEBS Lett; 2006 Aug; 580(18):4365-70. PubMed ID: 16846599
[TBL] [Abstract][Full Text] [Related]
13. Promising results of the chaperone effect caused by imino sugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease.
Sánchez-Ollé G; Duque J; Egido-Gabás M; Casas J; Lluch M; Chabás A; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2009; 42(2):159-66. PubMed ID: 19167250
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism for stabilization of a mutant α-galactosidase A involving M51I amino acid substitution by imino sugars.
Tsukimura T; Chiba Y; Ohno K; Saito S; Tajima Y; Sakuraba H
Mol Genet Metab; 2011 May; 103(1):26-32. PubMed ID: 21353612
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.
Kuriyama C; Kamiyama O; Ikeda K; Sanae F; Kato A; Adachi I; Imahori T; Takahata H; Okamoto T; Asano N
Bioorg Med Chem; 2008 Aug; 16(15):7330-6. PubMed ID: 18595718
[TBL] [Abstract][Full Text] [Related]
16. Introduction of
Kato A; Nakagome I; Yoshimura K; Kanekiyo U; Kishida M; Shinzawa K; Lu TT; Li YX; Nash RJ; Fleet GWJ; Tanaka N; Yu CY
Org Biomol Chem; 2022 Sep; 20(36):7250-7260. PubMed ID: 35838176
[TBL] [Abstract][Full Text] [Related]
17. Biological properties of D- and L-1-deoxyazasugars.
Kato A; Kato N; Kano E; Adachi I; Ikeda K; Yu L; Okamoto T; Banba Y; Ouchi H; Takahata H; Asano N
J Med Chem; 2005 Mar; 48(6):2036-44. PubMed ID: 15771446
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of somatostatin mimetics based on 1-deoxynojirimycin.
Chagnault V; Lalot J; Murphy PV
ChemMedChem; 2008 Jul; 3(7):1071-6. PubMed ID: 18418832
[TBL] [Abstract][Full Text] [Related]
19. Alglucosidase alfa: new drug. Pompe disease: a short-term benefit.
Prescrire Int; 2007 Dec; 16(92):240-1. PubMed ID: 18092404
[TBL] [Abstract][Full Text] [Related]
20. The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase.
Flanagan JJ; Rossi B; Tang K; Wu X; Mascioli K; Donaudy F; Tuzzi MR; Fontana F; Cubellis MV; Porto C; Benjamin E; Lockhart DJ; Valenzano KJ; Andria G; Parenti G; Do HV
Hum Mutat; 2009 Dec; 30(12):1683-92. PubMed ID: 19862843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
